Critical care issues in stroke and subarachnoid hemorrhage

Neurological Research

Volumn 24, Issue SUPPL. 1, 2002, Pages

  Kraus, J J ^a   Metzler, M D ^b   Coplin, W M ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mercy Hospital Iowa City   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Blood pressure; Brain swelling edema; Seizure; Stroke; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ANTICOAGULANT AGENT; HYPERTENSIVE AGENT;

ARTIFICIAL VENTILATION; BLOOD PRESSURE MONITORING; BRAIN BLOOD FLOW; ELECTROLYTE BALANCE; EXTUBATION; FLUID THERAPY; HEART ARRHYTHMIA; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTENSIVE CARE; INTRACRANIAL PRESSURE; INTUBATION; NUTRITION; PATIENT MONITORING; PROGNOSIS; REVIEW; SEDATION; SEIZURE; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT PLANNING; VASOSPASM; BLOOD PRESSURE; BRAIN VASOSPASM; CEREBROVASCULAR ACCIDENT; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; HUMAN; INTENSIVE CARE; INTRACRANIAL PRESSURE; SEIZURES; SUBARACHNOID HEMORRHAGE; SUPPORT, U.S. GOV'T, P.H.S.; VASOSPASM, INTRACRANIAL; HUMANS;

EID: 0036282320     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Advances in neurointensive care
2. Changes in intervention and outcome in elderly patients with subarachnoid hemorrhage
3. Treatment of acute ischemic stroke
4. Acute treatment of ischemic stroke
5. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature
6. Rapid sequence induction: A national survey of practice
7. The use of midazolam for prehospital rapid-sequence intubation may be associated with a dose-related increase in hypotension
8. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: Indications, timing, and outcome
9. Implications of extubation delay in brain-injured patients meeting standard weaning criteria
10. Weaning from mechanical ventilation
11. Cost and outcome of mechanical ventilation for life-threatening stroke
12. Mechanical ventilation in patients with acute ischemic stroke: Survival and outcome at one year
13. Influence of age on outcome of mechanically ventilated patients in an intensive care unit
14. Mechanical ventilation in patients with hemispheric ischemic stroke
15. Causes and outcome of mechanical ventilation in patients with hemispheric ischemic stroke
16. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension
17. Blood pressure during the first minutes of focal cerebral ischemia
18. Intensive care for acute stroke in the community hospital setting. The first 24 hours
19. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
20. Prescribing practices of antihypertensive agents in patients with ischemic stroke: Impact on patient outcome
21. Tissue plasminogen activator for acute ischemic stroke
22. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association
23. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage
24. Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage
25. Sequential changes of cerebral blood flow after aneurysmal subarachnoid haemorrhage
26. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage
27. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation)
28. Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders
29. QT dispersion after subarachnoid hemorrhage
30. Acute left ventricular dysfunction and subarachnoid hemorrhage
31. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy
32. Hemodynamic changes after cardioversion of chronic atrial fibrillation
33. Atrial fibrillation
34. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
35. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
36. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association
37. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats
38. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats
39. Relation between cerebral blood-flow and cerebral perfusion pressure
40. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage
41. Malignant cerebral edema and intra-cranial hypertension
42. Cerebral perfusion pressure: Management protocol and clinical results
43. Treatment options for large hemispheric stroke
44. Factors associated with hydrocephalus after aneurysmal subarachnoid hemorrhage
45. Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study
46. Block of arachnoid villus by subarachnoid hemorrhage
47. 'Malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs
48. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries
49. Guidelines for the management of severe head injury
50. Neurophysiologic monitoring in the neuroscience intensive care unit
51. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
52. Infection related to intracranial pressure monitors in adults: Analysis of risk factors and antibiotic prophylaxis
53. Ventriculostomy-related infections. A prospective epidemiologic study
54. Cerebral vasospasm
55. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care
56. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage
57. Protein kinase C and cerebral vasospasm
58. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients
59. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta-analysis
60. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements
61. Delayed ischemia due to cerebral vasospasm occult to transcranial Doppler. An important role for cerebral perfusion SPECT
62. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: A clinical, prospective, randomized, controlled study
63. Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol
64. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans
65. Intraarterial injection of amrinone for vasospasm induced by subarachnoid hemorrhage
66. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: Report of seven cases
67. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: Report of two cases
68. Intra-arterial papaverine-induced seizures: Case report and review of the literature
69. Physiologic consequences of status epilepticus
70. Status epilepticus
71. Treatment of status epilepticus with midazolam in the critical care setting
72. A comparison of four treatments for generalized convulsive status epilepticus
73. Treatment of status epilepticus: A prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin
74. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin
75. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration
76. Medical technology assessment EEG and evoked potentials in the intensive care unit
77. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department
78. Seizures in acute stroke: Predictors and prognostic significance. The Copenhagen Stroke Study
79. Seizures after stroke: A prospective multicenter study
80. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage
81. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
82. Use of sedative and analgesic agents in neurotrauma patients: Effects on cerebral physiology
83. Neuromuscular blocking agents in neurointensive care
84. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit
85. Remifentanil
86. Hypomagnesemia. A review of patho-physiological, clinical and therapeutical aspects
87. Fluid and electrolyte abnormalities
88. Hypernatremia
89. Hyponatremia in intracranial disorders
90. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy
91. Cerebral salt wasting syndrome
92. Pontine and extrapontine myelinolysis: A neurologic disorder following rapid correction of hyponatremia
93. Myelinolysis after correction of hyponatremia
94. Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome
95. Percutaneous endoscopic gastrostomy for patients with severe cerebral injury
96. Routine intragastric feeding following traumatic brain injury is safe and well tolerated
97. The refeeding syndrome: An approach to understanding its complications and preventing its occurrence
98. The importance of the refeeding syndrome
99. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke